@lancetmicrobe.bsky.socialOur October issue is now online:
www.thelancet.com/journals/lan...
Our journal is #OpenAccess, so you are free to explore all of our content. But these hashtags offer a flavour: #AMR #influenza #Streptococcus #Shigella #melioidosis #tuberculosis
@lancetmicrobe.bsky.socialNew review article
#MERS-CoV in Africa: a #OneHealth review of the silent reservoir
@lancetmicrobe.bsky.socialNew research article
Epidemiology and phylogenomic characterisation of the 2025 #Ebola virus disease outbreak in Bulape, Kasaï province, Democratic Republic of the Congo: a retrospective observational study
@npariente.bsky.social@lancetmicrobe.bsky.socialNew research article
Safety and immunogenicity of a recombinant vesicular stomatitis virus-based #SudanVirus #vaccine in adults in the USA: a single-blind, first-in-human, dose-escalation phase 1 clinical trial
@evogytis.bsky.socialbaltic v1.0.0 is live! Get it via pip or clone from Github repo. Now with documentation (baltic.readthedocs.io) & a gallery of tutorials & examples (phylo-baltic.github.io/baltic-gallery, still WIP). Huge thanks to @barney-potter.bsky.social for all the initiative & help along the way. #ViroSky
@cmicomms.bsky.social🎙️ Just published 'Does oseltamivir harm critically ill patients? The REMAP-CAP results'
Hosted by Erin McCreary, PharmD & Josh Davis with invited guests Steve Webb & Steven Tong 🌟
Listen on #Communicable https://ow.ly/pJAO50ZOfK8 or on #Breakpoints https://ow.ly/p8Ti50ZOfK9
@cmicomms.bsky.social📣 New #Communicable / #Breakpoints drops Mon 21 Sep!
Erin McCreary, PharmD & Josh Davis are joined by Steve Webb & Steven Tong to discuss REMAP-CAP results suggesting that oseltamivir may harm critically ill patients, while also highlighting the importance and impact of RCTs.
@plosbiology.org@lancetmicrobe.bsky.socialNew research article
Assessing #SARS-CoV-2 immune markers in vaccinated asymptomatic adults after household exposure in Canada (AB-PROTECT): a prospective cohort study
www.thelancet.com/journals/lan...
#IDSky #ClinMicro #MicroSky #ViroSky #COVID-19 #OpenAccess #OA
@lancetmicrobe.bsky.socialNew research article
#COVID-19 #vaccine effectiveness in people on immunosuppressive therapies: a systematic review and meta-analysis
www.thelancet.com/journals/lan...
#IDSky #ClinMicro #MicroSky #ViroSky #SARS-CoV-2 #OpenAccess #OA
@evogytis.bsky.socialBarney Potter & I are putting the finishing touches to the latest release of baltic set for Sep 22. If you're a current baltic user the refactored API will break things. The docs will help you navigate the new API: baltic.readthedocs.io/en/latest/in.... Preprint to follow soon. #ViroSky #EvoSky
@lancetmicrobe.bsky.socialOur September issue is now online:
www.thelancet.com/journals/lan...
Our journal is #OpenAccess, so you are free to explore all of our content. But these hashtags offer a flavour: #malaria #Aspergillus #hantavirus #tuberculosis #AMR #typhoid #mpox
@npariente.bsky.socialWe’re reposting some trending articles from our recent past, for those that may have missed them.
Below is an excellent resource from @aharms485.bsky.social lab expanding the BASEL phage collection
🧪#ViroSky #Microsky
@lancetmicrobe.bsky.socialNew research article
Bacterial co-detection in individuals with acute respiratory infections through a direct-to-consumer platform in China: a retrospective cross-sectional study
